Lymphedema Progression Screening Using MRI

Completed · Not applicable

Conditions studied: Lymphedema, Breast Cancer

In brief

This study will apply novel, noninvasive structural and functional magnetic resonance imaging (MRI) methods to patients with mild and moderate breast cancer-related lymphedema (BCRL) for the first time to test fundamental hypotheses about relationships between lymphatic compromise and imaging biomarkers that may portend disease progression and individualized therapy response.

Key facts

Study ID

NCT02611557

Run by

Vanderbilt University

People needed

90

Starts

2015-02-01

Expected to finish

2019-06-01

Last updated by the study team

2019-08-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• sex=female
• age=40-70 yrs
• clinical diagnosis of lymphedema secondary to breast cancer treatment (including node dissection, radiation therapy, and/or sentinel node biopsy).

You may not qualify if…

• Contraindication to MRI
• Bilateral axillary lymph node removal
• Primary lymphedema. Individuals on tyrosine kinase inhibitors or calcium channel blockers

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• Vanderbilt University — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.